Kwang Sik Park

Title: Kwang Sik Park: Innovator in Drug-Organic-Acid-Anhydride Conjugates

Introduction

Kwang Sik Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of drug-organic-acid-anhydride conjugates. His innovative approach has the potential to enhance drug delivery systems and improve therapeutic efficacy.

Latest Patents

Kwang Sik Park holds a patent for "Synthesizing drug-organic-acid-anhydride conjugates without using coupling reagent." This patent details a method for synthesizing a drug-organic-acid-anhydride conjugate using docetaxel as a drug. The process involves several steps, including mixing aconitic anhydride with a chlorinating reagent, dissolving the mixture in an organic solvent, stirring, evaporating the solvent, washing the resulting mixture, and finally mixing docetaxel with the aconitic anhydride chloride solution to produce the desired conjugate. This innovative method streamlines the synthesis process and eliminates the need for coupling reagents.

Career Highlights

Kwang Sik Park is currently associated with Cnpharm Co. Ltd., where he continues to advance his research in drug synthesis. His work has garnered attention for its potential applications in improving drug formulations and therapeutic outcomes. With a focus on innovative solutions, he is dedicated to enhancing the pharmaceutical landscape.

Collaborations

Kwang Sik Park collaborates with talented individuals in his field, including Hojun Kim and Guen-Woo Jin. These partnerships foster a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in drug synthesis.

Conclusion

Kwang Sik Park is a pioneering inventor whose work in synthesizing drug-organic-acid-anhydride conjugates represents a significant advancement in pharmaceutical science. His innovative methods and collaborations are paving the way for future developments in drug delivery systems.